Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose,…
Altimmune Inc, a clinical-stage biopharmaceutical company, announced that it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its single-dose, intranasal COVID-19 vaccine, named AdCOVID